Skip to main content
. 2021 May 3;15(5):e0009382. doi: 10.1371/journal.pntd.0009382

Table 1. Epidemiological and clinical characteristics at diagnosis of the 713-patient cohort treated with multibacillary multidrug therapy at Souza Araújo Outpatient Clinic, Fiocruz, during 1997–2017.

Characteristic Number of patients (valid %)
Sex
    Male 509 (71.4)
    Female 204 (28.6)
Educational level (years)
  •     0—informal

80 (11.4)
    <9 357 (50.8)
    9–11 134 (19.1)
    >11 131 (18.7)
Not available 11
Clinical Form
    Lepromatous leprosy 330 (46.3)
    Borderline-Lepromatous 237 (33.2)
    Borderline -Borderline 141 (19.7)
    Borderline-Tuberculoid 3 (0.4)
    Indeterminate 2 (0.3)
Number of skin lesions
      Single lesion 21 (3.6)
      2–5 lesions 46 (7.8)
      6–10 lesions 50 (8.5)
      11–20 lesions 294 (50.2)
      More than 20 lesions 175 (29.9)
      Not available 127
Treatment duration (months)*
    12 202 (28.3)
    13–18 491 (68.9)
    > 18 20 (2.8)
Disability grade Initial RFT
    0 (no disability) 362 (56.5) 331 (55.9)
    1 (anaesthesia/paresis) 180 (28.1) 187 (31.6)
    2 (deformity/ulcer) 99 (15.4) 74 (12.5)
Not available 72 121
Bacillary index Initial RFT (n = 531)
    0 0 (0.0) 98 (18.4)
    0.05–3.38 343 (48.5) 251 (47.2)
    ≥3.5 367 (51.5) 183 (34.4)
    Median 3.50 2.50
    Minimum, maximum 0.16, 6.00 0.0, 5.90
    First and third quartiles 1.75, 4.25 0.50, 3.76

*All patients received a twelve-dose MB-MDT scheme, but some were non-compliant with the monthly schedule or had to delay treatment due to adverse effect. Treatment duration was calculated using the date the patient received his/her first supervised dose until he/she received the last supervised dose, regardless the time taken to restart the treatment in case of non-compliance.

RFT = release from treatment